SPIA
HELP

Steward Partners Investment Advisory’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Steward Partners Investment Advisory’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,000
Closed -$11.8K – 4349
2025
Q3 		$11.8K Hold
2,000
– – ﹤0.01% 3330
2025
Q2 		$16.8K Hold
2,000
– – ﹤0.01% 2988
2025
Q1 		$12.7K Buy
+2,000
New +$17.3K ﹤0.01% 2991

Other funds holding HELP

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

Steward Partners Investment Advisory's HELP Position: Q4 2025 in Review

Steward Partners Investment Advisory sold out of Helus Pharma Inc. Common Stock (HELP) in Q4 2025, closing a stake of 2,000 shares — an estimated $11.8K sold.

Steward Partners Investment Advisory first reported a position in HELP in Q1 2025 and held it in 3 quarters. The position peaked at $16.8K in Q2 2025. 80 funds tracked by Wall St. Rank hold HELP as of Q4 2025.

  • Steward Partners Investment Advisory reported no remaining Helus Pharma Inc. Common Stock position as of Q4 2025 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 2,000 Helus Pharma Inc. Common Stock shares in Q4 2025, an estimated $11.8K.
  • Steward Partners Investment Advisory first reported a position in Helus Pharma Inc. Common Stock in Q1 2025 and held it in 3 quarters.
  • Steward Partners Investment Advisory's Helus Pharma Inc. Common Stock position peaked at $16.8K in Q2 2025.
  • 80 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q4 2025.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2025, filed 12 Feb 2026.